- Exchange: NASDAQ CM
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
CombiMatrix Corp
+ Add to WatchlistCBMX:US
3.3200 USD 0.0100 0.30%As of 20:10:00 ET on 05/17/2013.
Snapshot for CombiMatrix Corp (CBMX)
| Open: | 3.3599 | Day's Range: | 3.2400 - 3.3599 | Volume: | 92,372 |
|---|---|---|---|---|---|
| Previous Close: | 3.3100 | 52wk Range: | 1.4013 - 14.1400 | 1-Yr Rtn: | -64.30% |
Key Statistics for CBMX
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (ttm) | -6.8500 |
| Est. EPS (12/2013) | - |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 11.91 |
| Shares Outstanding (M) | 3.59 |
| 30 Day Average Volume | 292,544 |
| Price/Book (mrq) | 1.2965 |
| Price/Sale (ttm) | 0.7512 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/09/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for CBMX
Company Profile & Key Executives for CBMX
CombiMatrix Corporation is a biotechnology company. The Company developed technology to produce DNA arrays for use in identifying and determining the roles of genes, gene mutations, and proteins. The technology is used in genomics, proteomics, biosensors, drug discovery, drug development, diagnostics, combinatorial chemistry, material sciences, and nanotechnology.
| Mark McDonoughPresident/CEO | Scott R BurellCFO/Treasurer/Secretary |
| Richard D Hockett JrChief Medical Officer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
CBMX News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page